STAT+: The startup chasing ‘general biological intelligence’
Reported by STAT News · all stories from statnews.com
Editorial digest
This article discusses a new startup focused on developing what it terms 'general biological intelligence' using artificial intelligence.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/4/2026
STAT+: The biotech startups skipping AI for drug discovery
Some emerging biotechnology firms are choosing to bypass artificial intelligence tools when developing new pharmaceuticals.
- Trusted health newsroom9/2/2026
STAT+: How a former ARPA-H director’s startup is tackling AI’s ‘dumb problems’
A startup led by a former ARPA-H director is addressing common AI challenges.
- Trusted health newsroom8/5/2026
STAT+: Why Schrödinger CEO Ramy Farid changed how he’s thinking about AI
Schrödinger CEO Ramy Farid reassessed his views on AI.
- Trusted health newsroom10/8/2026
STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients
A startup is offering AI-driven breast cancer risk assessment directly to individuals.
- Trusted health newsroom10/21/2026
STAT+: What’s the deal with Isomorphic Labs?
A new report examines the current standing and operations of drug discovery venture Isomorphic Labs.
- Trusted health newsroom10/28/2026
STAT+: Why every health care AI company must face Epic
A report examines why developers of medical artificial intelligence must inevitably contend with electronic health record giant Epic.